Integrative multi-omics study identifies sex-specific molecular signatures and immune modulation in bladder cancer
These findings provide new insights into the molecular basis of sex differences in bladder cancer and could pave the way for more personalized and effective therapeutic strategies tailored to male and female patients.
Authors
- Xue Li (ORCID: https://orcid.org/0000-0001-9520-517X)
- Jason H. Moore (ORCID: https://orcid.org/0000-0002-5015-1099)
- Zhiping Paul Wang
- Priyanka Bhandary (ORCID: https://orcid.org/0000-0002-6962-9638)
- Yizhou Wang (ORCID: https://orcid.org/0000-0002-9378-745X)
- Kevin Griffin
Institutions
- Cedars-Sinai Medical Center (US)
Publication Details
- Journal
- Frontiers in Bioinformatics
- Published
- 2025-05-19
- DOI
- https://doi.org/10.3389/fbinf.2025.1575790
- Citations
- 3
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.02